Interview with Hervé Dussart , President, AstraZeneca Turkey
Even though you have delivered strong results in most of the markets you have been appointed, this is your first assignment as the head of a subsidiary. For a man…
Address: Büyükdere Cad. Yapı Kredi Plaza, B Blok, K:2-4, 34330 Levent – Istanbul / Turkey
,Turkey
Tel: +90 212 317 2300
Web: http://www.astrazeneca.com.tr/
Since 1999 with the mission to produce ideas that add value for the life of people spend their lives working for better quality, and performs a lot of research, AstraZeneca, has been undertaking major projects in Turkey within the framework of social responsibility . AstraZeneca to gain awareness of first aid at a young age, ‘First Aid’ project TOÇEV throughout Turkey and in conjunction with the Ministry of National Education conducts. Investigating the effects of socioeconomic and environmental factors on human health and will continue for 10 years, ‘Prospective Urban and Rural Epidemiology’ ‘PURE’ gold sponsor of the research all over the world. Continued under the leadership of our country, METSEND’in approximately 3000 people were included in this project. not only the disease-causing diseases, and investigating the causes and environments that support the work of public awareness in order to eliminate these causes, AstraZeneca, ‘Fast Forward-fast-forward’ approach, using the maximum to produce beneficial drugs, the patient needs to provide the most appropriate solutions and business processes through the developing world to adapt the driving force attack is considered.
AstraZeneca, research, development, prescription drugs, production, marketing and presentation of these services in the field, one of the most important international companies. Volume of $ 33 billion health care and chest infection, cardiology, gastroentereloji, oncology, central nervous system and leading position in diabetes care products offered by area is one of the world’s leading pharmaceutical companies
Even though you have delivered strong results in most of the markets you have been appointed, this is your first assignment as the head of a subsidiary. For a man…
Consumer healthcare products manufacturer Winalite is working to penetrate the Turkish market, but with regulations complicating bringing their portfolio from China, general manager Arafat Yadigar is looking to develop a…
Ozgur Tomruk, J&J’s Managing Director for Global Surgery talks about Turkey’s importance for the company, the priorities they have set, J&J’s commitment to quality and his ambition for the company’s…
Nil Tunaşar, managing partner of Transorient, discusses significance of tracking performance metrics among 3PL providers, the organization’s technology overhaul, and also highlights the type of logistics solutions encompassed under Transorient’s…
Matthias Diewald (MD) and Asli Volkan (AV) elaborate on HELM Kimya’s longstanding presence within Turkey and the type of market opportunities available for co-development and contract manufacturing. They also explain the…
Haluk Ataoglu, academic turned founder of Matriks Biotek®, talks about his aspirations for his company and the Turkish R&D landscape as well as how to penetrate the global pharmaceutical market…
Prof. Dr. Murat Özgören, the architect behind the ambitious BioIzmir project, talks about its potential and how it intends to educate new talent to address critical future needs of the…
BMS Turkey’s new general manager discusses Opdivo (nivolumab) their revolutionary new product for squamous non-small cell lung cancer, their registry of 1200 patients in Turkey with melanoma, potential developments in pharmaceutical…
Multinational R&D investment in Turkey, particularly investment in clinical trials, has been quite limited relative to the size of the Turkish pharmaceutical market. Turkish R&D spending amounted to just 0.95…
Over the past six years, Turkey has consistently lowered its drugs prices and guided its companies to greater efficiency. “Reference prices in Turkey are constructed from the lowest price in…
In the coming years, Turkey plans to prioritize R&D initiatives, health studies and medical innovation: that’s the core message Minister of Health Mehmet Müezzinoğlu gave PharmaBoardroom. This is the beginning…
Recep Altekin, the general manager of MT Sağlik – market leader in Turkey for blood glucose monitoring systems and diabetes test strips by volume – tells PharmaBoardroom about his company’s impact…
AstraZeneca’s Country President for Turkey discusses their efforts to build scientific leadership in Turkey in line with their global strategy and her hopes for the market access and public-private partnership…
See our Cookie Privacy Policy Here